메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색
질문

논문 기본 정보

자료유형
학술저널
저자정보
Su Jeen Lee (The Catholic University of Korea) Hun Kim (SK bioscience) Kee-Jong Hong (Konkuk University) Jae-Hwan Nam (The Catholic University of Korea)
저널정보
대한바이러스학회 JOURNAL OF BACTERIOLOGY AND VIROLOGY JOURNAL OF BACTERIOLOGY AND VIROLOGY Vol.51 No.3
발행연도
2021.9
수록면
103 - 111 (9page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

초록· 키워드

오류제보하기
Varicella zoster virus (VZV) causes two distinct diseases, varicella (chickenpox) during primary infection, and herpes zoster (shingles) resulting from reactivation. The purpose of this review is to summarize the present understanding of VZV and the associated immune response, as well as to discuss available vaccines. VZV infection induces both innate and adaptive immune responses, especially an antigen-specific adaptive immune response, which activates humoral immunity and cell-mediated immunity (CMI). Reactivation of VZV can occur when the CMI of latent VZV is reduced, leading to herpes zoster. After VZV infection, natural killer (NK) cells modulate antigen presentation and the production of IFN-γ, an important activator of macrophages. IFN-γ is produced by NK cells and CD4 Th1/CD8 cytotoxic T lymphocytes. The T cell-mediated immune response is an important factor influencing VZV reactivation and herpes zoster, with herpes zoster being associated with reduced levels of VZV-specific T cells. Since the VZV-specific T cell population gradually declines with age, herpes zoster particularly affects the elderly. There are two types of zoster vaccines: live-attenuated and recombinant subunit. However, recombinant vaccines generally have poor immunogenicity when administered alone and require an adjuvant. Therefore, effective adjuvants are needed that especially promote cell-mediated immune responses. Various adjuvants have been developed, many of which enhance T cell immunity more than antibody-based humoral immunity. The information presented in this review may serve as a reference for future VZV immunology studies.

목차

INTRODUCTION
IMMUNOLOGY OF VZV INFECTION
HERPES ZOSTER VACCINES AND IMMUNE RESPONSE
ADJUVANTS
CONCLUSION
REFERENCES

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

이 논문과 함께 이용한 논문

최근 본 자료

전체보기

댓글(0)

0

UCI(KEPA) : I410-ECN-0101-2021-475-002143181